New and Experimental Skin-Directed Therapies for Cutaneous Lymphomas

Publisher： Karger

E-ISSN： 1660-5535|22|6|322-334

ISSN： 1660-5527

Source： Skin Pharmacology and Physiology, Vol.22, Iss.6, 2009-09, pp. : 322-334

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Olopatadine Ameliorates Rat Experimental Cutaneous Inflammation by Improving Skin Barrier Function

By  

Pharmacology, Vol. 81, Iss. 2, 2007-10 ,pp. : 118-126

Karger

Access to resources Recommend Favorite

Improvement of the Experimental Setup to Assess Cutaneous Bioavailability on Human Skin Models: Dynamic Protocol

By  

Skin Pharmacology and Physiology, Vol. 15, Iss. 1, 2004-11 ,pp. : 31-39

Karger

Access to resources Recommend Favorite

Targeted Therapies for the Treatment of Pediatric Non-Hodgkin Lymphomas: Present and Future

By Sorge Caryn E.   McDaniel Jenny K.   Xavier Ana C.  

Pharmaceuticals, Vol. 9, Iss. 2, 2016-05 ,pp. : 28-28

MDPI

Access to resources Recommend Favorite

Center of Experimental and Applied Cutaneous Physiology

By  

Skin Pharmacology and Physiology, Vol. 14, Iss. 1, 2004-11 ,pp. : 2-3

Karger

Access to resources Recommend Favorite

Reconstructed Skin Kits: Reproducibility of Cutaneous Irritancy Testing

By  

Skin Pharmacology and Physiology, Vol. 15, Iss. 1, 2004-11 ,pp. : 74-91

Karger

Access to resources Recommend Favorite